Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,985
41 years, by papers

Newest first

3,751 to 3,800 of 3,985

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.

    International journal of clinical practice2004PMID 15529514

  • Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide.

    International journal of clinical practice2004PMID 15529516

  • Metformin in polycystic ovary syndrome.

    Current opinion in obstetrics & gynecology2004PMID 15534444

  • Does metformin induce ovulation in normoandrogenic anovulatory women?

    American journal of obstetrics and gynecology2004PMID 15547527

  • Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes.

    Diabetes care2004PMID 15562200

  • Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.

    The Journal of clinical endocrinology and metabolism2004PMID 15579760

  • Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.

    Gynecological endocrinology2004PMID 15697072

  • Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

    Clinical therapeutics2004PMID 15823767

  • Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.

    Diabetes, nutrition & metabolism2004PMID 15887629

  • Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetes.

    Diabetes & vascular disease research2004PMID 16305056

  • A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.

    Diabetes care2003PMID 12502668

  • Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.

    Diabetes care2003PMID 12502670

  • Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.

    The Journal of clinical endocrinology and metabolism2003PMID 12519844

  • A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.

    Fertility and sterility2003PMID 12524053

  • Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.

    Human reproduction (Oxford, England)2003PMID 12525441

  • Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin.

    Diabetes care2003PMID 12547847

  • Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial.

    Human reproduction (Oxford, England)2003PMID 12571165

  • Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.

    The American journal of the medical sciences2003PMID 12589230

  • Modulation of hunger by plasma glucose and metformin.

    The Journal of clinical endocrinology and metabolism2003PMID 12629096

  • Metformin blunts stress-induced hyperglycemia after thermal injury.

    The Journal of trauma2003PMID 12634538

  • Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

    The Journal of clinical endocrinology and metabolism2003PMID 12679450

  • Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.

    Diabetes, obesity & metabolism2003PMID 12681023

  • Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.

    Diabetes, obesity & metabolism2003PMID 12681024

  • Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients.

    Acta diabetologica2003PMID 12682825

  • Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.

    Hormone and metabolic research2003PMID 12734787

  • Effect of metformin on insulin sensitivity and insulin secretion in female obese patients with normal glucose tolerance.

    Diabetes & metabolism2003PMID 12746632

  • Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.

    Clinical therapeutics2003PMID 12749511

  • Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin.

    Diabetes research and clinical practice2003PMID 12757988

  • The comparison of clinical and hormonal parameters in PCOS patients treated with metformin and GnRH analogue.

    Archives of gynecology and obstetrics2003PMID 12768300

  • Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.

    The Journal of clinical endocrinology and metabolism2003PMID 12788862

  • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    The Cochrane database of systematic reviews2003PMID 12804446

  • Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen.

    Journal of diabetes and its complications2003PMID 12810245

  • Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.

    British journal of clinical pharmacology2003PMID 12814458

  • Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

    Diabetes care2003PMID 12832314

  • Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.

    Clinical therapeutics2003PMID 12852706

  • The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial.

    Gynecological endocrinology2003PMID 12857428

  • Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study.

    Metabolism: clinical and experimental2003PMID 12870162

  • Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.

    Diabetes care2003PMID 12882842

  • Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.

    Diabetes care2003PMID 12882864

  • Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.

    The Journal of clinical endocrinology and metabolism2003PMID 12915642

  • Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.

    The Cochrane database of systematic reviews2003PMID 12917943

  • Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2003PMID 12970273

  • Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.

    Collegium antropologicum2003PMID 12974145

  • Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.

    European journal of endocrinology2003PMID 14514347

  • Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

    Journal of internal medicine2003PMID 14535967

  • Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2003PMID 14557435

  • Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.

    The Journal of clinical endocrinology and metabolism2003PMID 14557446

  • Metformin in polycystic ovary syndrome: systematic review and meta-analysis.

    BMJ (Clinical research ed.)2003PMID 14576245

  • Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.

    Journal of managed care pharmacy2003PMID 14613469

  • Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.

    Diabetes, obesity & metabolism2003PMID 14617222

The next 50 papers

← Previous 50